Table 1.
45 disease-associated CNV regions. Cytogenic band and genomic coordinates (GRCh37/hg19) of the 45 unique, non-overlapping, disease-associated CNV regions (CNVRs) depicted on the x-axis of Fig. 2. For each CNVR, length in kilobase pairs is given (“Size”). “GD” indicates whether the CNVR matches any of the 92 genomic disorders (GD) compiled by Crawford et al. [24]: Y = “yes”; * = partial overlap with the 22q11.2 distal CNVR (chr22:21,920,000–23,650,000). Disease associations mapping to that CNVR are listed, with bold font indicating that the association is likely mediated by increased body mass index (BMI). All the models through which the association was detected at genome-wide significance are indicated in superscript: “U” = U-shape model; “ + ” = duplication-only model; “ − ” = deletion-only model; “M” = mirror model; CKD = chronic kidney disease; AKI = acute kidney injury
Cytogenic band | Chr | CNVR start | CNVR end | Size [kb] | GD | Disease associations |
---|---|---|---|---|---|---|
1p36.21 | 1 | 12,854,105 | 13,038,285 | 184 | Pulmonary embolismU,+,M | |
1q21.1-1q21.2 | 1 | 146,478,785 | 147,832,715 | 1,354 | Y | Chronic obstructive pulmonary diseaseU,+, emphysema+,M, iron deficiency anemiaU,+ |
2p12 | 2 | 78,376,475 | 78,680,202 | 304 | Disorders of bilirubin metabolismU, −,M | |
3p26.3 | 3 | 2,141,411 | 2,465,091 | 324 | Asthma+,M | |
3p12.2 | 3 | 80,344,634 | 83,400,564 | 3,056 | Disorders of mineral metabolism−,M | |
3q29 | 3 | 196,953,177 | 197,331,898 | 379 | Y | Alzheimer’s diseaseU |
4q28.3 | 4 | 136,510,759 | 136,952,267 | 442 | Cornea diseasesU, −,M | |
4q35.1-4q35.2 | 4 | 186,687,554 | 187,182,384 | 495 | Cornea diseasesU | |
5p14.3 | 5 | 20,254,182 | 20,924,403 | 670 | Systemic lupus erythematosusU | |
6p25.1 | 6 | 4,235,784 | 4,658,277 | 422 | Endometriosis−,M | |
6q26 | 6 | 162,705,164 | 162,873,489 | 168 | Sleep disorders−,M | |
7p22.1-7p21.3 | 7 | 7,260,027 | 7,504,011 | 244 | Aplastic anemiaU | |
7p21.2 | 7 | 15,074,783 | 15,249,515 | 175 | Bipolar disorder−,M | |
7q31.2-7q31.31 | 7 | 117,399,981 | 119,333,169 | 1,933 | Chronic obstructive pulmonary diseaseU,+,M | |
7q36.3 | 7 | 158,530,132 | 158,953,160 | 423 | Ovarian cancerU,+,M | |
8p22 | 8 | 17,599,136 | 17,719,930 | 121 | Cardiac valve disordersU | |
10p14 | 10 | 6,677,540 | 6,833,390 | 156 | EpilepsyU | |
10q26.3 | 10 | 135,217,002 | 135,237,176 | 20 | Sleep apnea− | |
11p15.4 | 11 | 5,322,902 | 5,417,034 | 94 | Parkinson’s diseaseU, −,M | |
12q24.33 | 12 | 131,611,538 | 131,825,359 | 214 | Psoriasis+,M | |
15q13.2-15q13.3 | 15 | 30,912,719 | 32,516,949 | 1,604 | Y | AKI+, anemiaU,+, asthma−,M, hemorrhagic strokeU |
15q26.3 | 15 | 101,319,208 | 101,613,151 | 294 | Vitamin B12 anemiaU,+,M | |
16p13.13-16p13.12 | 16 | 12,516,765 | 12,659,427 | 143 | Sleep apneaU | |
16p13.11 | 16 | 15,120,501 | 16,353,166 | 1,233 | Y | Epilepsy−, hypertensionU, kidney stones− |
16p12.2 | 16 | 21,946,523 | 22,440,319 | 494 | Y | Cardiac conduction disordersU, −,M, disease burdenU, −,M, hypertension−,M, pneumonia−, |
16p11.2 BP2-BP3 | 16 | 28,775,159 | 29,043,450 | 268 | Y | Anemia−, cholelithiasis−,M |
16p11.2 BP4-BP5 | 16 | 29,596,230 | 30,208,637 | 612 | Y | AKIU, −,M, anemiaU, −, asthma−, bipolar disorderU,+,M, chronic obstructive pulmonary diseaseU, −,M, CKDU, −, disease burdenU, −,M, epilepsy−, hypertension−, lipidemias and lipoprotein disorders−, pneumoniaU, −,M, recurrent depressive disorderU,+,M, schizophreniaU,+,M, sleep apnea−,M, type I diabetes−, vitamin B12 anemiaU |
16q23.3 | 16 | 82,954,230 | 83,133,760 | 180 | Emphysema− | |
17p13.3 | 17 | 631,380 | 738,187 | 107 | Epilepsy−,M | |
17p13.2 | 17 | 4,378,105 | 4,498,641 | 121 | Pulmonary embolismM | |
17q12 | 17 | 34,755,219 | 36,249,489 | 1,494 | Y | CKDU,+,M |
17q21.31 | 17 | 41,197,733 | 41,276,111 | 78 | Ovarian cancer−,M | |
18p11.32 | 18 | 685,968 | 1,266,259 | 580 | Kidney stonesU,+ | |
19p13.3 | 19 | 6,873,527 | 6,881,286 | 8 | Systemic lupus erythematosusU,+,M | |
19p13.2 | 19 | 11,210,904 | 11,218,188 | 7 | Ischemic heart disease− | |
20p12.1 | 20 | 14,523,969 | 14,652,973 | 129 | GoutU | |
22q11.21 | 22 | 19,024,651 | 21,463,545 | 2,439 | Y | Aneurysm−, headaches+,M, ischemic heart diseaseU,+,M |
22q11.21-22q11.22 | 22 | 21,797,101 | 22,661,627 | 865 | * | Disorders of mineral metabolism−,M |
22q11.23 | 22 | 23,627,256 | 23,658,006 | 31 | * | Disorders of bilirubin metabolism−,M |
22q12.1 | 22 | 25,929,538 | 25,994,013 | 64 | GlaucomaU, − | |
Xp22.33 | X | 1,746,850 | 2,046,202 | 299 | Sleep apneaM | |
Xp22.33 | X | 2,128,228 | 2,361,712 | 233 | Disease burdenU,+,M | |
Xp22.33 | X | 2,814,160 | 2,945,477 | 131 | Celiac diseaseU | |
Xp22.11 | X | 22,946,631 | 23,087,940 | 141 | Ovarian cancerU, −,M | |
Xq28 | X | 152,703,776 | 152,887,811 | 184 | Ovarian cancerU,+,M |